Annie Im

The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment: a multicenter randomized controlled trial

Daniel Wolff, Steffen Fieuws, Carlos Graux, 2018, Haematologica.

Phase 1 clinical trial of adoptive immunotherapy using "off-the-shelf" activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia.

Hong Wang, Cliona M Rooney, Anastasios Raptis, 2017, Cytotherapy.